Sam D Sanderson

This inventor holds 12 USPTO granted patents and 2 published patent applications. Top assignees: The Board of Regents of the University of Nebraska, San Diego State University Research Foundation, The University of Queensland. Active years: 1997-2026.

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 83.3

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 31(Granted Patents)

Company Filing History:

11 out of 967

The Board of Regents of the University of Nebraska

patents

2 out of 112

San Diego State University Research Foundation

patents

2 out of 345

The University of Queensland

patents

4. 1 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552848 - HYDROCHLORIDE SALTS OF C5A RECEPTOR AGONIST PEPTIDES (2026-02-17),

2. 10945962 - Controlled-release peptide compositions and uses thereof (2021-03-16),

3. 10363282 - Analogs of C5a and methods of using same (2019-07-30),

4. 10220002 - Controlled-release peptide compositions and uses thereof (2019-03-05),

5. 9895411 - Analogs of C5a and methods of using same (2018-02-20),

6. 7358087 - Compositions and methods for enhancing immune responses mediated by antigen-presenting cells (2008-04-15),

7. 7291336 - Compositions and methods for enhancing immune responses mediated by antigen-presenting cells (2007-11-06),

8. 7063847 - Compositions and methods for enhancing immune responses mediated by antigen-presenting cells (2006-06-20),

9. 6821517 - Compositions and methods for enhancing immune responses mediated by antigen-presenting cells (2004-11-23),

10. 6465614 - High-affinity response-selective C-terminal analogs of C5a anaphylatoxin (2002-10-15),

11. 5942599 - High-affinity response-selective C-terminal analogs of C5a anaphylatoxin (1999-08-24),

12. 5696230 - High-affinity response-selective C-terminal analogs of C5a anaphylatoxin (1997-12-09),

Title: The Innovative Journey of Sam D Sanderson

Introduction: Sam D Sanderson, a pioneering inventor hailing from Omaha, Nebraska, has made significant contributions to the world of innovations with his creative mindset and dedication to progress.

Latest Patents: Sam D Sanderson holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on cutting-edge advancements in renewable energy and sustainable materials.

Career Highlights: Throughout his illustrious career, Sam D Sanderson has been recognized for his groundbreaking inventions that have revolutionized industries. His innovative spirit has led to the development of products that enhance efficiency and sustainability.

Collaborations: Sam D Sanderson has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible solutions that benefit society.

Conclusion: Sam D Sanderson's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire future generations to push the boundaries of what is possible.